Correlation Between Enlivex Therapeutics and PsyBio Therapeutics

Can any of the company-specific risk be diversified away by investing in both Enlivex Therapeutics and PsyBio Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Enlivex Therapeutics and PsyBio Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Enlivex Therapeutics and PsyBio Therapeutics Corp, you can compare the effects of market volatilities on Enlivex Therapeutics and PsyBio Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Enlivex Therapeutics with a short position of PsyBio Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Enlivex Therapeutics and PsyBio Therapeutics.

Diversification Opportunities for Enlivex Therapeutics and PsyBio Therapeutics

0.0

Correlation Coefficient

Enlivex Therapeutics  PsyBio Therapeutics

Pay attention - limited upside

The 3 months correlation between Enlivex and PsyBio is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Enlivex Therapeutics and PsyBio Therapeutics Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on PsyBio Therapeutics Corp and Enlivex Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Enlivex Therapeutics are associated (or correlated) with PsyBio Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of PsyBio Therapeutics Corp has no effect on the direction of Enlivex Therapeutics i.e., Enlivex Therapeutics and PsyBio Therapeutics go up and down completely randomly.

Pair Corralation between Enlivex Therapeutics and PsyBio Therapeutics

Given the investment horizon of 90 days Enlivex Therapeutics is expected to under-perform the PsyBio Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Enlivex Therapeutics is 8.21 times less risky than PsyBio Therapeutics. The stock trades about -0.01 of its potential returns per unit of risk. The PsyBio Therapeutics Corp is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest  4.68  in PsyBio Therapeutics Corp on December 5, 2024 and sell it today you would lose (4.67) from holding PsyBio Therapeutics Corp or give up 99.79% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	99.8%
Values	Daily Returns

Enlivex Therapeutics  vs.  PsyBio Therapeutics Corp

Enlivex Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Enlivex Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's essential indicators remain fairly stable which may send shares a bit higher in April 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

PsyBio Therapeutics Corp

Risk-Adjusted Performance

Very Weak

Over the last 90 days PsyBio Therapeutics Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable fundamental drivers, PsyBio Therapeutics is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

Pair Trading with Enlivex Therapeutics and PsyBio Therapeutics

The main advantage of trading using opposite Enlivex Therapeutics and PsyBio Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Enlivex Therapeutics position performs unexpectedly, PsyBio Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in PsyBio Therapeutics will offset losses from the drop in PsyBio Therapeutics' long position.

The idea behind Enlivex Therapeutics and PsyBio Therapeutics Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.